GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis

S. Kurita, Justin L Mott, L. L. Almada, S. F. Bronk, N. W. Werneburg, S. Y. Sun, L. R. Roberts, M. E. Fernandez-Zapico, G. J. Gores

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through its cognate receptors death receptor 4 (DR4) and death receptor 5 (DR5), preferentially in malignant cells. However, many malignant cells remain resistant to TRAIL cytotoxicity by poorly characterized mechanisms. Here, using cholangiocarcinoma cells, as a model for TRAIL resistance, we identified a role for the oncogenic Hedgehog (Hh)-GLI pathway in the regulation of TRAIL cytotoxicity. Blockade of Hh using pharmacological and genetic tools sensitizes the cells to TRAIL cytotoxicity. Restoration of apoptosis sensitivity coincided with upregulation of DR4 expression, while expression of other death effector proteins remained unaltered. Knockdown of DR4 mimics Hh-mediated resistance to TRAIL cytotoxicity. Hh regulates the expression of DR4 by modulating the activity of its promoter. Luciferase, chromatin immunoprecipitation and expression assays show that the transcription factor GLI3 binds to the DR4 promoter and Hh requires an intact GLI3-repression activity to silence DR4 expression. Finally, small interfering RNA (siRNA)-targeted knockdown of GLI3, but not GLI1 or GLI2, restores DR4 expression and TRAIL sensitivity, indicating that the Hh effect is exclusively mediated by this transcription factor. In conclusion, these data provide evidence of a regulatory mechanism, which modulates TRAIL signaling in cancer cells and suggest new therapeutic approaches for TRAIL-resistant neoplasms.

Original languageEnglish (US)
Pages (from-to)4848-4858
Number of pages11
JournalOncogene
Volume29
Issue number34
DOIs
StatePublished - Aug 26 2010

Fingerprint

TNF-Related Apoptosis-Inducing Ligand Receptors
Apoptosis
Transcription Factors
Cholangiocarcinoma
Chromatin Immunoprecipitation
Luciferases
Small Interfering RNA
Neoplasms
Up-Regulation
Tumor Necrosis Factor-alpha
Pharmacology
Ligands

Keywords

  • GLI transcription factors
  • TRAIL
  • apoptosis
  • cholangiocarcinoma

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Kurita, S., Mott, J. L., Almada, L. L., Bronk, S. F., Werneburg, N. W., Sun, S. Y., ... Gores, G. J. (2010). GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis. Oncogene, 29(34), 4848-4858. https://doi.org/10.1038/onc.2010.235

GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis. / Kurita, S.; Mott, Justin L; Almada, L. L.; Bronk, S. F.; Werneburg, N. W.; Sun, S. Y.; Roberts, L. R.; Fernandez-Zapico, M. E.; Gores, G. J.

In: Oncogene, Vol. 29, No. 34, 26.08.2010, p. 4848-4858.

Research output: Contribution to journalArticle

Kurita, S, Mott, JL, Almada, LL, Bronk, SF, Werneburg, NW, Sun, SY, Roberts, LR, Fernandez-Zapico, ME & Gores, GJ 2010, 'GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis', Oncogene, vol. 29, no. 34, pp. 4848-4858. https://doi.org/10.1038/onc.2010.235
Kurita, S. ; Mott, Justin L ; Almada, L. L. ; Bronk, S. F. ; Werneburg, N. W. ; Sun, S. Y. ; Roberts, L. R. ; Fernandez-Zapico, M. E. ; Gores, G. J. / GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis. In: Oncogene. 2010 ; Vol. 29, No. 34. pp. 4848-4858.
@article{c4ec15fcb5a045908a3a704d19d2aec5,
title = "GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis",
abstract = "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through its cognate receptors death receptor 4 (DR4) and death receptor 5 (DR5), preferentially in malignant cells. However, many malignant cells remain resistant to TRAIL cytotoxicity by poorly characterized mechanisms. Here, using cholangiocarcinoma cells, as a model for TRAIL resistance, we identified a role for the oncogenic Hedgehog (Hh)-GLI pathway in the regulation of TRAIL cytotoxicity. Blockade of Hh using pharmacological and genetic tools sensitizes the cells to TRAIL cytotoxicity. Restoration of apoptosis sensitivity coincided with upregulation of DR4 expression, while expression of other death effector proteins remained unaltered. Knockdown of DR4 mimics Hh-mediated resistance to TRAIL cytotoxicity. Hh regulates the expression of DR4 by modulating the activity of its promoter. Luciferase, chromatin immunoprecipitation and expression assays show that the transcription factor GLI3 binds to the DR4 promoter and Hh requires an intact GLI3-repression activity to silence DR4 expression. Finally, small interfering RNA (siRNA)-targeted knockdown of GLI3, but not GLI1 or GLI2, restores DR4 expression and TRAIL sensitivity, indicating that the Hh effect is exclusively mediated by this transcription factor. In conclusion, these data provide evidence of a regulatory mechanism, which modulates TRAIL signaling in cancer cells and suggest new therapeutic approaches for TRAIL-resistant neoplasms.",
keywords = "GLI transcription factors, TRAIL, apoptosis, cholangiocarcinoma",
author = "S. Kurita and Mott, {Justin L} and Almada, {L. L.} and Bronk, {S. F.} and Werneburg, {N. W.} and Sun, {S. Y.} and Roberts, {L. R.} and Fernandez-Zapico, {M. E.} and Gores, {G. J.}",
year = "2010",
month = "8",
day = "26",
doi = "10.1038/onc.2010.235",
language = "English (US)",
volume = "29",
pages = "4848--4858",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "34",

}

TY - JOUR

T1 - GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis

AU - Kurita, S.

AU - Mott, Justin L

AU - Almada, L. L.

AU - Bronk, S. F.

AU - Werneburg, N. W.

AU - Sun, S. Y.

AU - Roberts, L. R.

AU - Fernandez-Zapico, M. E.

AU - Gores, G. J.

PY - 2010/8/26

Y1 - 2010/8/26

N2 - Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through its cognate receptors death receptor 4 (DR4) and death receptor 5 (DR5), preferentially in malignant cells. However, many malignant cells remain resistant to TRAIL cytotoxicity by poorly characterized mechanisms. Here, using cholangiocarcinoma cells, as a model for TRAIL resistance, we identified a role for the oncogenic Hedgehog (Hh)-GLI pathway in the regulation of TRAIL cytotoxicity. Blockade of Hh using pharmacological and genetic tools sensitizes the cells to TRAIL cytotoxicity. Restoration of apoptosis sensitivity coincided with upregulation of DR4 expression, while expression of other death effector proteins remained unaltered. Knockdown of DR4 mimics Hh-mediated resistance to TRAIL cytotoxicity. Hh regulates the expression of DR4 by modulating the activity of its promoter. Luciferase, chromatin immunoprecipitation and expression assays show that the transcription factor GLI3 binds to the DR4 promoter and Hh requires an intact GLI3-repression activity to silence DR4 expression. Finally, small interfering RNA (siRNA)-targeted knockdown of GLI3, but not GLI1 or GLI2, restores DR4 expression and TRAIL sensitivity, indicating that the Hh effect is exclusively mediated by this transcription factor. In conclusion, these data provide evidence of a regulatory mechanism, which modulates TRAIL signaling in cancer cells and suggest new therapeutic approaches for TRAIL-resistant neoplasms.

AB - Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through its cognate receptors death receptor 4 (DR4) and death receptor 5 (DR5), preferentially in malignant cells. However, many malignant cells remain resistant to TRAIL cytotoxicity by poorly characterized mechanisms. Here, using cholangiocarcinoma cells, as a model for TRAIL resistance, we identified a role for the oncogenic Hedgehog (Hh)-GLI pathway in the regulation of TRAIL cytotoxicity. Blockade of Hh using pharmacological and genetic tools sensitizes the cells to TRAIL cytotoxicity. Restoration of apoptosis sensitivity coincided with upregulation of DR4 expression, while expression of other death effector proteins remained unaltered. Knockdown of DR4 mimics Hh-mediated resistance to TRAIL cytotoxicity. Hh regulates the expression of DR4 by modulating the activity of its promoter. Luciferase, chromatin immunoprecipitation and expression assays show that the transcription factor GLI3 binds to the DR4 promoter and Hh requires an intact GLI3-repression activity to silence DR4 expression. Finally, small interfering RNA (siRNA)-targeted knockdown of GLI3, but not GLI1 or GLI2, restores DR4 expression and TRAIL sensitivity, indicating that the Hh effect is exclusively mediated by this transcription factor. In conclusion, these data provide evidence of a regulatory mechanism, which modulates TRAIL signaling in cancer cells and suggest new therapeutic approaches for TRAIL-resistant neoplasms.

KW - GLI transcription factors

KW - TRAIL

KW - apoptosis

KW - cholangiocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=77956179100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956179100&partnerID=8YFLogxK

U2 - 10.1038/onc.2010.235

DO - 10.1038/onc.2010.235

M3 - Article

VL - 29

SP - 4848

EP - 4858

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 34

ER -